218 related articles for article (PubMed ID: 8502242)
1. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.
Lund J; Takahashi N; Nakagawa H; Goodall M; Bentley T; Hindley SA; Tyler R; Jefferis R
Mol Immunol; 1993 Jun; 30(8):741-8. PubMed ID: 8502242
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of human IgG subclass and mouse IgG2b heavy chains secreted by mouse J558L transfectoma cell lines as chimeric antibodies.
Lund J; Takahashi N; Hindley S; Tyler R; Goodall M; Jefferis R
Hum Antibodies Hybridomas; 1993 Jan; 4(1):20-5. PubMed ID: 8431554
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
4. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
[TBL] [Abstract][Full Text] [Related]
5. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
[TBL] [Abstract][Full Text] [Related]
6. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
7. Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors.
Lund J; Takahashi N; Pound JD; Goodall M; Nakagawa H; Jefferis R
FASEB J; 1995 Jan; 9(1):115-9. PubMed ID: 7821750
[TBL] [Abstract][Full Text] [Related]
8. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
9. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Tao MH; Morrison SL
J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation of the variable region of immunoglobulin G--site specific maturation of the sugar chains.
Endo T; Wright A; Morrison SL; Kobata A
Mol Immunol; 1995 Sep; 32(13):931-40. PubMed ID: 7476998
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum.
Wuhrer M; Stam JC; van de Geijn FE; Koeleman CA; Verrips CT; Dolhain RJ; Hokke CH; Deelder AM
Proteomics; 2007 Nov; 7(22):4070-81. PubMed ID: 17994628
[TBL] [Abstract][Full Text] [Related]
12. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
Gawlitzek M; Ryll T; Lofgren J; Sliwkowski MB
Biotechnol Bioeng; 2000 Jun; 68(6):637-46. PubMed ID: 10799988
[TBL] [Abstract][Full Text] [Related]
13. The polypeptide of immunoglobulin G influences its galactosylation in vivo.
Lee SO; Connolly JM; Ramirez-Soto D; Poretz RD
J Biol Chem; 1990 Apr; 265(10):5833-9. PubMed ID: 2108149
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
[TBL] [Abstract][Full Text] [Related]
16. Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptors.
Derebe MG; Nanjunda RK; Gilliland GL; Lacy ER; Chiu ML
Immunol Lett; 2018 May; 197():1-8. PubMed ID: 29476755
[TBL] [Abstract][Full Text] [Related]
17. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
Wright A; Morrison SL
J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins.
Jefferis R; Lund J; Mizutani H; Nakagawa H; Kawazoe Y; Arata Y; Takahashi N
Biochem J; 1990 Jun; 268(3):529-37. PubMed ID: 2363690
[TBL] [Abstract][Full Text] [Related]
19. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
20. Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones.
Bergwerff AA; Stroop CJ; Murray B; Holtorf AP; Pluschke G; Van Oostrum J; Kamerling JP; Vliegenthart JF
Glycoconj J; 1995 Jun; 12(3):318-30. PubMed ID: 7496147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
